Health Catalyst, Inc. (HCAT) Stock Price & Analysis
Health Catalyst, Inc. (HCAT) rose 3.48% to USD 2.08 as of July 25, 2026 at 07:16 UTC, according to Nexqual real-time market data.
HCAT last closed at USD 2.01; the session ranged USD 2.01–2.11 on volume of 421,079 shares. Market capitalization is $153.70M, with a 52-week range of USD 0.96–4.12 (NMS). Source: Nexqual, July 25, 2026 at 07:16 UTC.
Key Statistics (as of July 25, 2026 at 07:16 UTC)
| Price | USD 2.08 |
|---|---|
| Change | ▲ 3.48% (up) |
| Previous Close | USD 2.01 |
| Open | USD 2.01 |
| Day Range | USD 2.01 – 2.11 |
| 52-Week Range | USD 0.96 – 4.12 |
| Volume | 421,079 shares |
| Market Cap | $153.70M |
| Exchange | NMS |
Technical Analysis (HCAT)
Nexqual's technical model rates HCAT "BUY" based on 4 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 07:16 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 48.13 (neutral) |
| vs SMA50 | Above (USD 1.78) |
| MACD | 0.08 (positive) |
Analyst Ratings (HCAT)
Wall Street analysts rate HCAT "Buy" based on 5 analysts, with a mean price target of USD 2.25 (range USD 1.75–3), per Nexqual as of July 25, 2026 at 07:16 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 5 |
| Mean Target | USD 2.25 |
| High Target | USD 3 |
| Low Target | USD 1.75 |
| Buy / Hold / Sell | 2 / 5 / 0 |
Earnings (HCAT)
| Next Earnings Date | 2026-08-06 |
|---|---|
| EPS Estimate | USD 0.03 |
| Revenue Estimate | $68.94M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.02 vs est 0.01 ▲ beat |
| 2025-12-31 | USD 0.08 vs est 0.1 ▼ miss |
| 2025-09-30 | USD 0.06 vs est 0.07 ▼ miss |
| 2025-06-30 | USD 0.04 vs est 0.04 ▲ beat |
Source: Nexqual, July 25, 2026 at 07:16 UTC.
Financials & Fundamentals (HCAT)
| Total Revenue | $302.48M |
|---|---|
| Revenue Growth (YoY) | -10.90% |
| Gross Margin | +50.44% |
| Operating Margin | -9.54% |
| Profit Margin | -87.70% |
| ROE | -103.02% |
| Debt / Equity | 123.48 |
| Current Ratio | 1.69 |
| Total Cash | $108.82M |
| Total Debt | $170.58M |
| Free Cash Flow | $23.99M |
Source: Nexqual, July 25, 2026 at 07:16 UTC.
Financial Health Score (HCAT)
Nexqual rates Health Catalyst, Inc.'s overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 07:16 UTC.
| Growth | Mixed — Revenue +1.5% YoY (annual), slow |
|---|---|
| Profitability | Mixed — Gross margin 50%, operating -10% |
| Balance Sheet | Mixed — $109M cash vs $171M debt |
| Cash Flow | Solid — FCF $24M, 8% margin |
| Efficiency | Critical — ROE -103%, ROA -3.5% |
Ownership (HCAT)
| Insider Ownership | +5.48% |
|---|---|
| Institutional Ownership | +77.77% |
| Shares Outstanding | 73.89M |
| Float | 58.65M |
| Short % of Float | +6.09% |
Source: Nexqual, July 25, 2026 at 07:16 UTC.
Leadership (HCAT)
Health Catalyst, Inc. is led by Benjamin Albert (age 52), CEO & Director, per Nexqual as of July 25, 2026 at 07:16 UTC.
| CEO & Director | Benjamin Albert (age 52) |
|---|---|
| Chief Financial Officer | Jason Alger (age 41) |
| Chief Strategy Officer & Senior VP of Corporate Development | Kyle J. Salyers |
| Chief Marketing Officer | Carrie Kozlowski OT |
| Senior Vice President of International | Jeffrey P. Selander |
Major Backers & Investors (HCAT)
Notable institutional backers of Health Catalyst, Inc. include First Light Asset Management, LLC, Cdc Financial, Inc., Whetstone Capital Advisors, LLC, according to Nexqual as of July 25, 2026 at 07:16 UTC.
Active Investors
| Investor | Stake |
|---|---|
| First Light Asset Management, LLC | 17.43% |
| Cdc Financial, Inc. | 8.54% |
| Whetstone Capital Advisors, LLC | 5.78% |
| Nepsis, Inc. | 4.03% |
| Palogic Value Management, LP | 3.92% |
| Impax Asset Management Group plc | 3.72% |
| IMPAX FUNDS SERIES TRUST I-Impax Small Cap Fund | 3.72% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 9.93% |
| Vanguard Group | 8.15% |
| Geode Capital | 2.03% |
Source: Nexqual, July 25, 2026 at 07:16 UTC.
From Health Catalyst, Inc.'s Latest SEC 10-K Filing (filed 2026-03-12)
Key Strengths & Strategy (as disclosed to the SEC)
- Industry-agnostic analytics companies that help healthcare organizations develop homegrown solutions include IBM, Databricks, Snowflake, Microsoft, Tableau CRM, and Qlik.
- Our professional services experts combine industry-leading talent across multiple domain areas with a deep working knowledge of our technology to help our clients achieve a faster time-to-value and drive more meaningful and sustainable measurable improvements.
- Intellectual Property We rely on a combination of patent, trademark, and copyright laws in the United States as well as confidentiality procedures and contractual provisions to protect our intellectual property and trade secrets, including proprietary technology, databases, and our brand.
- Ignite has amassed large and comprehensive data assets, which enables us to deliver differentiated insights to our clients. • Applications.
Partnerships
- Our culture promotes an environment where team members trust each other, strive to continually learn, are motivated to lead hard-working yet balanced lives, make decisions with integrity and humility in mind, communicate openly and honestly, embrace teamwork and collaboration, and enjoy their days at work.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PHR | Phreesia, Inc. | USD 10.22 | ▲ 2.1% |
| LOB | Live Oak Bancshares, Inc. | USD 42.08 | ▲ 2.51% |
| HQY | HealthEquity, Inc. | USD 94.64 | ▼ 1.37% |
| PGNY | Progyny, Inc. | USD 31.19 | ▼ 0.51% |
| EVH | Evolent Health, Inc | USD 4.22 | ▼ 24.24% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 07:16 UTC. This page is informational and not investment advice.